Richard O Williams Selected Research

Experimental Arthritis

1/2022	Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression.
1/2021	TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis.
10/2019	TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells.
1/2019	Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis.
1/2018	ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.
1/2018	T cell activation Rho GTPase activating protein (TAGAP) is upregulated in clinical and experimental arthritis.
2/2016	Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade.
1/2016	Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.
1/2016	Targeted IL-4 therapy synergizes with dexamethasone to induce a state of tolerance by promoting Treg cells and macrophages in mice with arthritis.
10/2014	Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard O Williams Research Topics

Disease

33	Rheumatoid Arthritis 01/2022 - 01/2004
28	Experimental Arthritis 01/2022 - 01/2002
27	Arthritis (Polyarthritis) 01/2022 - 03/2003
18	Inflammation (Inflammations) 09/2021 - 12/2004
7	Necrosis 08/2011 - 12/2004
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2005
5	Pain (Aches) 09/2021 - 10/2008
4	Osteoarthritis 01/2022 - 10/2008
4	Disease Progression 01/2019 - 01/2014
2	Ankylosing Spondylitis 01/2021 - 08/2007
2	Synovitis 12/2016 - 01/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015 - 08/2007
2	Multiple Sclerosis 09/2012 - 10/2008
1	Autoimmune Diseases of the Nervous System 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Carcinogenesis 01/2022
1	Obesity 09/2021
1	Myocarditis (Carditis) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Cerebral Malaria 01/2020
1	Trypanosomiasis 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Osteoporosis 01/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Stroke (Strokes) 01/2019
1	Infections 01/2018
1	Atherosclerosis 10/2015
1	Atherosclerotic Plaque (Atheroma) 10/2015

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2022 - 03/2003
13	Collagen Type II (Type II Collagen)IBA 01/2019 - 03/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 12/2004
5	KynurenineIBA 01/2022 - 05/2009
5	Interleukin-17 (Interleukin 17)IBA 01/2019 - 10/2008
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2008
4	Pharmaceutical PreparationsIBA 11/2021 - 10/2010
4	anthranilic acid (anthranilate)IBA 01/2020 - 01/2013
4	Etanercept (Enbrel)FDA Link 02/2016 - 01/2007
3	CollagenIBA 01/2022 - 08/2010
3	EnzymesIBA 01/2022 - 01/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2007
3	ChemokinesIBA 01/2019 - 10/2015
3	Tryptophan (L-Tryptophan)FDA Link 10/2015 - 05/2009
3	Monoclonal AntibodiesIBA 01/2010 - 04/2008
2	AntigensIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 08/2010
2	AcidsIBA 01/2020 - 01/2020
2	Phosphodiesterase 4 InhibitorsIBA 01/2019 - 01/2010
2	Biological ProductsIBA 10/2017 - 04/2008
2	Therapeutic UsesIBA 01/2016 - 01/2002
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 10/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 08/2011
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 09/2014 - 05/2009
2	Peroxidase (Myeloperoxidase)IBA 01/2014 - 08/2011
2	nimesulide (Aulin)IBA 01/2014 - 10/2010
2	Antisense OligonucleotidesIBA 04/2009 - 10/2008
1	carfilzomibIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	SubtilisinIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	invariant chain (Ii-Key)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	EmulsionsIBA 01/2022
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2021
1	Decitabine FDA Link 11/2021
1	Calcium Gluconate (CBG)IBA 09/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	idelalisibIBA 01/2021
1	ibrutinibIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SteroidsIBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2019
1	ibudilastIBA 01/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Immunoglobulin Fc FragmentsIBA 01/2018
1	rho GTPase-activating proteinIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	DX-2400IBA 02/2016
1	Peptide Hydrolases (Proteases)FDA Link 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 02/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2016
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	arginine deiminaseIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 10/2015
1	LipidsIBA 10/2015
1	N-(3',4'-dimethoxycinnamonyl)anthranilic acidIBA 10/2015
1	AntibodiesIBA 01/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 02/2004
2	Analgesia 08/2015 - 01/2014
1	Aftercare (After-Treatment) 01/2019